Literature DB >> 18474127

Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries.

C-H Chuang1, L-H Su, J Perera, C Carlos, B H Tan, G Kumarasinghe, T So, P H VAN, A Chongthaleong, P-R Hsueh, J-W Liu, J-H Song, C-H Chiu.   

Abstract

Two hundred and four Salmonella enterica serotype Typhi (S. Typhi) isolates were collected from seven Asian countries during 2002-2004. Multidrug-resistant S. Typhi (resistant to > or = 3 antibiotics) was detected in 84 (41.2%) isolates and 142 (69.6%) showed reduced susceptibility to ciprofloxacin (minimum inhibitory concentration=0.125-1.0 mg/l). This study highlights the worsening situation of antimicrobial resistance of S. Typhi in Asia.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18474127     DOI： 10.1017/S0950268808000745

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  11 in total

1.  Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever.

Authors:  Kanika Deshpande Koirala; Duy Pham Thanh; Sudeep Dhoj Thapa; Amit Arjyal; Abhilasha Karkey; Sabina Dongol; Upendra Man Shrestha; Jeremy J Farrar; Buddha Basnyat; Stephen Baker
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

2.  Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.

Authors:  Christopher M Parry; Chau Tran Thuy; Sabina Dongol; Abhilasha Karkey; Ha Vinh; Nguyen Tran Chinh; Pham Thanh Duy; Tran Vu Thieu Nga; James I Campbell; Nguyen Van Minh Hoang; Amit Arjyal; Zulfiqar A Bhutta; Sujit K Bhattacharya; Magdarina D Agtini; Baiqing Dong; Do Gia Canh; Aliya Naheed; John Wain; Tran Tinh Hien; Buddha Basnyat; Leon Ochiai; John Clemens; Jeremy J Farrar; Christiane Dolecek; Stephen Baker
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

3.  Elucidation of Antimicrobial Susceptibility Profiles and Genotyping of Salmonella enterica Isolates from Clinical Cases of Salmonellosis in New Mexico in 2008.

Authors:  Kenneth P Smith; Jeffy George; Kathleen M Cadle; Sanath Kumar; Steven J Aragon; Ricardo L Hernandez; Suzanna E Jones; Jody L Floyd; Manuel F Varela
Journal:  World J Microbiol Biotechnol       Date:  2010-06-01       Impact factor: 3.312

Review 4.  Global trends in typhoid and paratyphoid Fever.

Authors:  John A Crump; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

5.  Non-typhoidal Salmonella gastroenteritis at a diarrheal hospital in Dhaka, Bangladesh, 1996-2011.

Authors:  Daniel T Leung; Sumon K Das; M A Malek; Dilruba Ahmed; Farhana Khanam; Firdausi Qadri; A S G Faruque; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2013-01-28       Impact factor: 2.345

Review 6.  Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever.

Authors:  Lalith Wijedoru; Sue Mallett; Christopher M Parry
Journal:  Cochrane Database Syst Rev       Date:  2017-05-26

7.  The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy.

Authors:  Christopher M Parry; Ha Vinh; Nguyen Tran Chinh; John Wain; James I Campbell; Tran Tinh Hien; Jeremy J Farrar; Stephen Baker
Journal:  PLoS Negl Trop Dis       Date:  2011-06-21

8.  YqiC of Salmonella enterica serovar Typhimurium is a membrane fusogenic protein required for mice colonization.

Authors:  Mariela C Carrica; Patricio O Craig; Víctor A García-Angulo; Andes Aguirre; Eleonora García-Véscovi; Fernando A Goldbaum; Silvio L Cravero
Journal:  BMC Microbiol       Date:  2011-05-09       Impact factor: 3.605

9.  Typhoid fever among children, Ghana.

Authors:  Florian Marks; Yaw Adu-Sarkodie; Frank Hünger; Nimako Sarpong; Samuel Ekuban; Alex Agyekum; Bernard Nkrumah; Norbert G Schwarz; Michael O Favorov; Christian G Meyer; Jürgen May
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

10.  Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial.

Authors:  Samir Koirala; Buddha Basnyat; Amit Arjyal; Olita Shilpakar; Kabina Shrestha; Rishav Shrestha; Upendra Man Shrestha; Krishna Agrawal; Kanika Deshpande Koirala; Sudeep Dhoj Thapa; Abhilasha Karkey; Sabina Dongol; Abhishek Giri; Mila Shakya; Kamal Raj Pathak; James Campbell; Stephen Baker; Jeremy Farrar; Marcel Wolbers; Christiane Dolecek
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.